Critical hypokalemic renal tubular acidosis due to Sjögren's syndrome: Association with the purported immune stimulant echinacea [3]

Clinical Rheumatology

Volumn 22, Issue 2, 2003, Pages 158-159

  Logan, J L ^a   Ahmed, J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOGALACTAN; CYCLOPHOSPHAMIDE; ECHINACEA EXTRACT; HYDROXYCHLOROQUINE; HYPERICUM PERFORATUM EXTRACT; IMMUNOSTIMULATING AGENT; KAVA EXTRACT; PREDNISONE; PYRROLIZIDINE ALKALOID;

ADULT; ANAMNESIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CASE REPORT; DISEASE COURSE; DISEASE EXACERBATION; DRUG MECHANISM; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOKALEMIA; IMMUNOSTIMULATION; KIDNEY TUBULE ACIDOSIS; LABORATORY TEST; LETTER; METABOLIC DISORDER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYMPTOMATOLOGY;

ACIDOSIS, RENAL TUBULAR; ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIRHEUMATIC AGENTS; CITRATES; ECHINACEA; ELECTROLYTES; FEMALE; FLUID THERAPY; HUMANS; HYDROXYCHLOROQUINE; HYPERICUM; HYPOKALEMIA; KAVA; POTASSIUM CHLORIDE; SJOGREN'S SYNDROME; WATER-ELECTROLYTE IMBALANCE;

EID: 0037972400     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-002-0671-4     Document Type: Letter

References (14)

1. Pun K-K, Wong C-K, Tsui EY-L, Tam S C-F, Kung A W-C, Wang C C-L (1989) Hypokalemic periodic paralysis due to the Sjögren's Syndrome in Chinese patients. Ann Intern Med 110: 405-406
2. Christensen KS (1985) Hypokalemic paralysis in Sjögren's Syndrome secondary to renal tubular acidosis. Scand J Rheumatol 14:58-60
3. Pertovaara M, Korpela M, Kouri T, Pasternack A (1999) The occurrence of renal involvement in primary Sjögren's Syndrome: a study of 78 patients. Rheumatology (Oxford) 38:1113-1120
4. + -ATPase pump in the collecting duct of a patient with hypokalemic distal renal tubular acidosis and Sjögren's Syndrome. J Am Soc Nephrol 6:295-301
5. Vitali C, Bombardieri S, Moutsopoulos HM et al. (1993) Preliminary criteria for the classification of Sjögren's Syndrome. Results of a prospective concerted action supported by the European community. Arthritis Rheum 36:340-346
6. Ohtani J, Imai H, Kodama T et al. (1999) Severe hypokalemia and respiratory arrest due to renal tubular acidosis in a patient with Sjögren's Syndrome. Nephrol Dial Transplant 14: 2201-2203
7. Zawadzki J (1998) Permeability defect with bicarbonate leak as a mechanism of immune-related distal renal tubular acidosis. Am J Kidney Dis 31:527-532
8. See DM, Broumand N, Sahl L, Tilles JG (1997) In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 35:229-235
9. Luettig B, Steinmuller C, Gifford GE, Wagner H, Lohmann-Matthes M-L (1989) Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J. Natl Cancer Inst 81:669-675
10. Rehman J, Dillow JM, Carter SM, Chou J, Le B, Maisel AS (1999) Increased production of antigen-specific immunoglobulins G and M following in vivo treatment with the medicinal plants Echinacea angustifolia and Hydrastis canadensis. Immunol Lett 68:391-395
11. Giles JT, Palat CT, Chien SH, Chang ZG, Kennedy DT (2000) Evaluation of echinacea for treatment of the common cold. Pharmacotherapy 20:690-697
12. Mengs U, Clare CB, Poiley JA (1991) Toxicity of Echinacea purpurea. Arzneim-Forsch/Drug Res 41:1076-1081
13. Kim HY, Stermitz FR, Molyneux RJ et al. (1993). Structural influences on pyrrolizidine alkaloid-induced cytopathology. Toxicol Appl Pharmacol 122:61-69
14. Boullata J, Nace A (2000) Safety issues with herbal medicine. Pharmacotherapy 20:257-269